Your browser doesn't support javascript.
loading
Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy.
Okamura, Yukiyasu; Yasukawa, Satoru; Narimatsu, Hiroto; Boku, Narikazu; Fukutomi, Akira; Konishi, Masaru; Morinaga, Soichiro; Toyama, Hirochika; Kaneoka, Yuji; Shimizu, Yasuhiro; Nakamori, Shoji; Sata, Naohiro; Yamakita, Keisuke; Takahashi, Amane; Kainuma, Osamu; Hishinuma, Shoichi; Yamaguchi, Ryuzo; Nagino, Masato; Hirano, Satoshi; Yanagisawa, Akio; Mori, Keita; Uesaka, Katsuhiko.
Affiliation
  • Okamura Y; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital, Nagaizumi, Japan.
  • Yasukawa S; Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Narimatsu H; Cancer Prevention and Control Division, Kanagawa Cancer Center, Yokohama, Japan.
  • Boku N; Gastrointestinal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Fukutomi A; Gastrointestinal Oncology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Konishi M; Hepato-Biliary-Pancreatic Surgery, National Cancer Center Hospital East, Kashiwa, Japan.
  • Morinaga S; Department of Gastrointestinal Surgery, Kanagawa Cancer Center, Yokohama, Japan.
  • Toyama H; Hepato-Biliary-Pancreatic Surgery, Kobe University, Kobe, Japan.
  • Kaneoka Y; Surgery, Ogaki Municipal Hospital, Ogaki, Japan.
  • Shimizu Y; Gastrointestinal Surgery, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Nakamori S; Surgery, National Hospital Organization Osaka National Hospital, Osaka, Japan.
  • Sata N; Gastrointestinal Surgery, Jichi Medical University, Shimotsuke, Japan.
  • Yamakita K; Division of Metabolism and Biosystemic Science, Department of Medicine, Asahikawa Medical University, Asahikawa, Japan.
  • Takahashi A; Gastrointestinal Surgery, Saitama Cancer Center, Saitama, Japan.
  • Kainuma O; Gastrointestinal Surgery, Chiba Cancer Center, Chiba, Japan.
  • Hishinuma S; Surgery, Tochigi Cancer Center, Utsunomiya, Japan.
  • Yamaguchi R; Surgery, Kasugai Municipal Hospital, Kasugai, Japan.
  • Nagino M; Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate of School of Medicine, Nagoya, Japan.
  • Hirano S; Gastroenterological Surgery II, Faculty of Medicine, Hokkaido University, Sapporo, Japan.
  • Yanagisawa A; Pathology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Mori K; Clinical Trial Coordination Office Biostatistician, Shizuoka Cancer Center Hospital, Nagaizumi, Japan.
  • Uesaka K; Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital, Nagaizumi, Japan.
Cancer Sci ; 111(2): 548-560, 2020 Feb.
Article in En | MEDLINE | ID: mdl-31778273
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Pancreatectomy / Pancreatic Neoplasms / Tegafur / Equilibrative Nucleoside Transporter 1 / Antimetabolites, Antineoplastic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2020 Type: Article Affiliation country: Japan
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Pancreatectomy / Pancreatic Neoplasms / Tegafur / Equilibrative Nucleoside Transporter 1 / Antimetabolites, Antineoplastic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Sci Year: 2020 Type: Article Affiliation country: Japan